NX 1838 aptamer angiogenesis blocker targeting vascular endothelial growth factor (VEGF): phase I does-escalation

NeXstar Pharmaceuticals Inc. (NXTR), Boulder, Colo. Product: NX 1838 aptamer angiogenesis blocker targeting vascular endothelial growth factor (VEGF) Indication: Treat age-related macular degeneratio...